KaydedilenlerDerginizi ekleyin

Dergiler / Turkish Journal of Medical Sciences / 2017 / Cilt: 47 - Sayı: 5

Investigation of class-d beta-lactamases causing carbapenem resistance in clinical Acinetobacter baumannii isolates*

Bayrı ERAÇ
Iskandar DAVANDEH
Sabire Şöhret AYDEMİR
Sayfa
1661–1666
Yayın Tarihi
2022-11-05
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: Molecular fingerprinting revealed that most imipenem-resistant A. baumannii strains were clonally related. blaOXA-23-group and blaOXA-51-groupwere mostly responsible for the imipenem resistance of the examined A. baumannii strains.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/aim: Acinetobacter baumannii is an important causative agent of nosocomial infections, and carbapenems have been frequently used in the treatment of these infections.
📊
Temel Bulgular & Veri:Materials and methods: Minimum inhibitory concentration (MIC) values of 76 imipenem nonsusceptible A. baumannii strains, isolated from a tertiary care hospital, were determined by microdilution method.
💡
Sonuç & Katkı:Conclusion: Molecular fingerprinting revealed that most imipenem-resistant A. baumannii strains were clonally related. blaOXA-23-group and blaOXA-51-groupwere mostly responsible for the imipenem resistance of the examined A. baumannii strains.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Background/aim: Acinetobacter baumannii is an important causative agent of nosocomial infections, and carbapenems have been frequently used in the treatment of these infections. This study was designed to investigate the prevalence of primary carbapenem hydrolyzing oxacillinase (CHO) types in clinical A. bumannii strains. Materials and methods: Minimum inhibitory concentration (MIC) values of 76 imipenem nonsusceptible A. baumannii strains, isolated from a tertiary care hospital, were determined by microdilution method. The clonal relationship of the isolates was analyzed with enterobacterial repetitive intergenic consensus (ERIC)-PCR, and the presence of CHO major groups (OXA-23; OXA-24, OXA-51, and OXA-58 groups) was investigated with multiplex PCR. Results: According to the ERIC-PCR patterns, the isolates were distributed in 13 different clones, the largest of which had 40 members. blaOXA-51-groupwas detected in representatives of all clones, whereas blaOXA-23-groupwas detectedin representatives of all but two small clones. Additionally, the presence of blaOXA-58-groupwas discovered in the members of two small clones, whereas blaOXA-24-groupwas not encountered in any of the examined strains. Conclusion: Molecular fingerprinting revealed that most imipenem-resistant A. baumannii strains were clonally related. blaOXA-23-group and blaOXA-51-groupwere mostly responsible for the imipenem resistance of the examined A. baumannii strains.

🔖

Bu Makaleye Atıf Yap

ERAÇ, B., DAVANDEH, I., AYDEMİR, S. Ş. (2022). Investigation of class-d beta-lactamases causing carbapenem resistance in clinical Acinetobacter baumannii isolates*. Turkish Journal of Medical Sciences, Cilt: 47 - Sayı: 5, 1661–1666. https://ajindex.com/articles/610988

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Nowak P, Paluchowska P, Budak A. Distribution of blaOXA genes among carbapenem-resistant Acinetobacter baumannii nosocomial strains in Poland. New Microbiol 2012; 35: 317- 325
  2. Garnacho-Montero J, Amaya-Vıllar R. Multiresistant Acinetobacter baumannii infections: epidemiology and management. Curr Opin Infect Dis 2010; 23: 332-339
  3. Poirel L, Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 2006; 12: 826-836
  4. Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, Amyes SGB, Livermore DM. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicro Ag 2006; 27: 351-353
  5. Opazo A, Domínguez M, Bello H, Amyes SGB, GonzálezRocha G. OXA-type carbapenemases in Acinetobacter baumannii in South America. J Infect Dev Countr 2012; 6: 311- 316
  6. Djahmi N, Dunyach-Remy C, Pantel A, Dekhil M, Sotto A, Lavigne JP. Epidemiology of carbapenemase-producing enterobacteriaceae and Acinetobacter baumannii in Mediterranean countries. BioMed Res Int 2014; Article ID: 305784,
  7. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Wayne, PA, USA: Clinical and Laboratory Standards Institute, 2000
  8. Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007; 24: 1596-1599
  9. Sohrabi N, Farajnia S, Akhi MT, Nahaei MR, Naghili B, Peymani A, Amiri Z, Rezaee MA, Saeedi N. Prevalence of OXA-type b-lactamases among Acinetobacter baumannii isolates from northwest of Iran. Microb Drug Resist 2012; 18: 385-389
  10. Coelho J, Woodford N, Afzal-Shah M, Livermore D. Occurrence of OXA-58-like carbapenemases in Acinetobacter spp. collected over 10 years in three continents. Antimicrob Agents Chemother 2006; 50: 756-758
  11. Ergin A, Hascelik G, Eser OK. Molecular characterization of oxacillinases and genotyping of invasive Acinetobacter baumannii isolates using repetitive extragenic palindromic sequence-based polymerase chain reaction in Ankara between 2004 and 2010. Scand J Infect Dis 2013; 45: 26-31
  12. Köseoğlu Eser Ö, Ergin A, Tunçkanat F, Hasçelik G. In vitro activity of tigecycline as a therapeutic option against multidrugresistant Acinetobacter spp. New Microbiol 2008; 31: 535-542
  13. Gur D, Korten V, Unal S, Deshpande LM, Castanheira M. Increasing carbapenem resis